$3.86
Comments
Loading...
Perspective Therapeutics Informe de interés a corto plazo
CATXAMEX
Informe de interés en corto
El interés corto en Perspective Therapeutics Inc (AMEX:CATX) ha aumentado durante el último período de informe, aumentando en aumento desde 6.37M hasta 6.67M. Esto representa el 12.72% de las acciones disponibles públicamente de la empresa.
El interés en corto en Perspective Therapeutics Corp (XASE:CATX) disminuyó durante el último período de informe, cayendo de 280,30 millones a 275,20 millones. Esto hizo que el 1,17 % de las acciones disponibles públicamente de la empresa se pusieran en corto.
Basado en el volumen promedio reciente de 817.33K acciones negociadas por día, tomaría 8.16 día(s) para que los poseedores de este interés corto cierren sus posiciones sin impulsar bruscamente el precio de las acciones.
Interés en corto
6.67M
Interés en corto %
12.7%
Días para cubrir
8.16
Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|
CATX | Perspective Therapeutics, Inc. | 09/15/2025 | 09/24/2025 | 12.72% | 52,456,457 | 6,671,693 | 817,331 | 8.16 | |
CATX | Perspective Therapeutics, Inc. | 08/29/2025 | 09/10/2025 | 12.15% | 52,456,457 | 6,373,501 | 598,669 | 10.65 | |
CATX | Perspective Therapeutics, Inc. | 08/15/2025 | 08/26/2025 | 11.98% | 52,456,457 | 6,285,168 | 670,362 | 9.38 | |
CATX | Perspective Therapeutics, Inc. | 07/31/2025 | 08/11/2025 | 12.39% | 52,421,801 | 6,496,317 | 769,260 | 8.44 | |
CATX | Perspective Therapeutics, Inc. | 07/15/2025 | 07/24/2025 | 12.11% | 52,421,801 | 6,347,204 | 1,179,926 | 5.38 | |
CATX | Perspective Therapeutics, Inc. | 06/30/2025 | 07/10/2025 | 11.91% | 52,421,801 | 6,242,706 | 1,662,123 | 3.76 | |
CATX | Perspective Therapeutics, Inc. | 06/13/2025 | 06/25/2025 | 10.71% | 52,421,801 | 5,616,516 | 2,077,510 | 2.7 | |
CATX | Perspective Therapeutics, Inc. | 05/30/2025 | 06/10/2025 | 10.07% | 52,421,801 | 5,278,241 | 884,200 | 5.97 | |
CATX | Perspective Therapeutics, Inc. | 05/15/2025 | 05/27/2025 | 10.79% | 52,421,801 | 5,654,023 | 590,376 | 9.58 | |
CATX | Perspective Therapeutics, Inc. | 04/30/2025 | 05/09/2025 | 10.08% | 52,244,308 | 5,266,566 | 688,368 | 7.65 | |
CATX | Perspective Therapeutics, Inc. | 04/15/2025 | 04/25/2025 | 9.61% | 52,244,308 | 5,022,843 | 1,161,618 | 4.32 | |
CATX | Perspective Therapeutics, Inc. | 03/31/2025 | 04/09/2025 | 9.21% | 61,998,104 | 5,710,412 | 639,697 | 8.93 | |
CATX | Perspective Therapeutics, Inc. | 03/14/2025 | 03/25/2025 | 10.70% | 55,533,803 | 5,939,698 | 518,201 | 11.46 | |
CATX | Perspective Therapeutics, Inc. | 02/28/2025 | 03/11/2025 | 10.64% | 55,533,803 | 5,909,500 | 644,244 | 9.17 | |
CATX | Perspective Therapeutics, Inc. | 02/14/2025 | 02/26/2025 | 9.87% | 55,533,803 | 5,480,817 | 553,735 | 9.9 | |
CATX | Perspective Therapeutics, Inc. | 01/31/2025 | 02/11/2025 | 9.76% | 55,533,803 | 5,417,505 | 1,088,511 | 4.98 | |
CATX | Perspective Therapeutics, Inc. | 01/15/2025 | 01/27/2025 | 13.75% | 55,533,803 | 7,633,209 | 1,197,831 | 6.37 | |
CATX | Perspective Therapeutics, Inc. | 12/31/2024 | 01/10/2025 | 16.08% | 55,533,803 | 8,931,987 | 1,297,306 | 6.89 | |
CATX | Perspective Therapeutics, Inc. | 12/13/2024 | 12/24/2024 | 17.85% | 55,533,803 | 9,912,952 | 1,444,394 | 6.86 | |
CATX | Perspective Therapeutics, Inc. | 11/29/2024 | 12/10/2024 | 18.81% | 55,533,803 | 10,445,797 | 4,413,970 | 2.37 | |
CATX | Perspective Therapeutics, Inc. | 11/15/2024 | 11/26/2024 | 14.90% | 55,533,803 | 8,277,033 | 907,121 | 9.12 | |
CATX | Perspective Therapeutics, Inc. | 10/31/2024 | 11/11/2024 | 14.49% | 55,373,930 | 8,022,108 | 598,624 | 13.4 | |
CATX | Perspective Therapeutics, Inc. | 10/15/2024 | 10/24/2024 | 14.23% | 55,373,930 | 7,881,299 | 1,178,000 | 6.69 | |
CATX | Perspective Therapeutics, Inc. | 09/30/2024 | 10/09/2024 | 17.32% | 55,373,930 | 9,589,415 | 1,286,675 | 7.45 | |
CATX | Perspective Therapeutics, Inc. | 09/13/2024 | 09/24/2024 | 12.90% | 55,373,930 | 7,141,541 | 817,551 | 8.74 | |
CATX | Perspective Therapeutics, Inc. | 08/30/2024 | 09/11/2024 | 11.60% | 55,373,930 | 6,422,919 | 708,983 | 9.06 | |
CATX | Perspective Therapeutics, Inc. | 08/15/2024 | 08/26/2024 | 12.55% | 55,373,930 | 6,951,430 | 572,854 | 12.13 | |
CATX | Perspective Therapeutics, Inc. | 07/31/2024 | 08/09/2024 | 12.25% | 55,360,754 | 6,782,317 | 624,628 | 10.86 | |
CATX | Perspective Therapeutics, Inc. | 07/15/2024 | 07/24/2024 | 11.98% | 55,360,754 | 6,633,966 | 857,396 | 7.74 | |
CATX | Perspective Therapeutics, Inc. | 06/28/2024 | 07/10/2024 | 7.78% | 55,360,754 | 4,306,555 | 2,047,392 | 2.1 | |
CATX | Perspective Therapeutics, Inc. | 06/14/2024 | 06/26/2024 | 53.88% | 55,360,754 | 29,826,776 | 6,916,174 | 4.31 | |
CATX | Perspective Therapeutics, Inc. | 05/31/2024 | 06/11/2024 | 4.23% | 553,607,549 | 23,435,459 | 7,390,953 | 3.17 | |
CATX | Perspective Therapeutics, Inc. | 05/15/2024 | 05/24/2024 | 3.04% | 502,091,669 | 15,259,104 | 6,262,659 | 2.44 | |
CATX | Perspective Therapeutics, Inc. | 04/30/2024 | 05/09/2024 | 2.91% | 466,378,608 | 13,594,041 | 4,785,758 | 2.84 | |
CATX | Perspective Therapeutics, Inc. | 04/15/2024 | 04/24/2024 | 2.24% | 466,378,608 | 10,432,695 | 7,970,727 | 1.31 | |
CATX | Perspective Therapeutics, Inc. | 03/28/2024 | 04/09/2024 | 1.74% | 466,378,608 | 8,092,736 | 3,712,028 | 2.18 | |
CATX | Perspective Therapeutics, Inc. | 03/15/2024 | 03/26/2024 | 0.32% | 584,680,051 | 1,880,666 | 4,428,801 | 1 | |
CATX | Perspective Therapeutics, Inc. | 02/29/2024 | 03/11/2024 | 0.32% | 584,565,051 | 1,872,350 | 1,409,623 | 1.33 | |
CATX | Perspective Therapeutics, Inc. | 02/15/2024 | 02/27/2024 | 0.61% | 492,358,673 | 3,005,886 | 2,755,405 | 1.09 | |
CATX | Perspective Therapeutics, Inc. | 01/31/2024 | 02/09/2024 | 0.42% | 492,358,673 | 2,053,847 | 2,762,832 | 1 | |
CATX | Perspective Therapeutics, Inc. | 01/12/2024 | 01/24/2024 | 0.39% | 492,358,673 | 1,934,411 | 2,534,752 | 1 | |
CATX | Perspective Therapeutics, Inc. | 12/29/2023 | 01/10/2024 | 0.69% | 278,335,100 | 1,932,877 | 1,472,166 | 1.31 | |
CATX | Perspective Therapeutics, Inc. | 12/15/2023 | 12/27/2023 | 0.65% | 278,335,100 | 1,808,113 | 373,541 | 4.84 | |
CATX | Perspective Therapeutics, Inc. | 11/30/2023 | 12/11/2023 | 0.66% | 278,335,100 | 1,840,409 | 242,327 | 7.59 | |
CATX | Perspective Therapeutics, Inc. | 11/15/2023 | 11/27/2023 | 0.69% | 278,335,100 | 1,932,984 | 314,813 | 6.14 | |
CATX | Perspective Therapeutics, Inc. | 10/31/2023 | 11/09/2023 | 0.74% | 278,335,100 | 2,048,452 | 312,960 | 6.55 | |
CATX | Perspective Therapeutics, Inc. | 10/13/2023 | 10/24/2023 | 0.69% | 278,335,100 | 1,928,051 | 305,777 | 6.31 | |
CATX | Perspective Therapeutics, Inc. | 09/29/2023 | 10/10/2023 | 0.73% | 278,335,100 | 2,029,917 | 4,693,238 | 1 |
En busca de los valores más cortos?